INS and type 2 diabetes mellitus: We used the item and number of oral antidiabetic drugs, insulin, DCSI scores, and duration of T2D as proxy variables to balance the severity of T2D and the number of HbA1c check-ups per year as a proxy variable to evaluate the healthy user bias between metformin users and nonusers and increase their comparability.